RETURN TO OUR ROOTS

Reconnecting with our mission as an engine of discovery and impact

Thursday, February 1 – Friday, February 2

The Ritz Carlton, Half Moon Bay

We are witnessing the start of a new era in biomedicine and health care, ignited by remarkable advances in the biological sciences, technology, and information sciences. The opportunities are boundless, and the challenges equally daunting. Now more than ever, this moment demands clarity – of our vision and understanding our purpose. At our 2024 Leadership Retreat, we will look back at our foundational legacy of leadership in research, education, and patient care. And with this touchstone, we will move biomedicine forward, discussing our roadmap through this decade and the opportunity to harness our tripartite mission—once again—as an engine of progress for the world.

Thursday, February 1, 2024

Friday, February 2, 2024

AGENDA

Thursday, February 1, 2024 | [10:00 AM - 4:00 PM]

9:00–10:00 am

Registration, REFRESHMENTS, AND RESEARCH INNOVATION SHOWCASE

Researchers from across Stanford Medicine will be available to talk about their cutting-edge work and answer questions on Thursday, February 1, before the sessions begin and over the lunch hour.

Stop by before the morning sessions begin (9:00 – 10:00 am) and during lunch (12:00 – 1:15 pm) to get one-on-one time with the teams and talk about the future of medicine.

10:00–10:30 am

Welcome

Lloyd Minor

Lloyd Minor

Dean of the Stanford School of Medicine
Vice President for Medical Affairs, Stanford University | BIO

10:30–11:00 am 

PANEL: AGE OF INTELLIGENCE – PREPARING FOR AI IN BIOMEDICINE

In this panel session, speakers will dive deep into the implications of AI for biomedicine, addressing its potential and pitfalls and how Stanford Medicine can shape its future through our tripartite mission.

Speakers:

Peter Lee

Peter Lee

Corporate Vice President, Research and Incubations, Microsoft | BIO

Mildred Cho

Mildred Cho

Professor (Research) of Pediatrics (Center for Biomedical Ethics) and of Medicine
(Primary Care and Population Health), Stanford School of Medicine | BIO

Sherri Rose

Sherri Rose

Professor of Health Policy, Stanford School of Medicine | BIO

Moderator:

Lloyd Minor

Lloyd Minor

Dean of the Stanford School of Medicine
Vice President for Medical Affairs, Stanford University | BIO

11:00 AM–12:00 pm 

BASIC SCIENCE SPOTLIGHTS

Fundamental discovery is synonymous with our preeminence in biomedicine. In this session, four basic scientists will highlight their innovative research – representing the groundbreaking work happening in labs across Stanford Medicine.

Kacper Rogala

Kacper Rogala

Starving Resilient Cancer Cells for Nutrients
Assistant Professor of Structural Biology and of Chemical and Systems Biology, Stanford School of Medicine | BIO

Ruth Huttenhain

Ruth Huttenhain

Snapshots of Molecular Networks in Space and Time
Assistant Professor of Molecular and Cellular Physiology, Stanford School of Medicine | BIO

Kyle Daniels

Kyle Daniels

Learning the Language of Signaling Domains to Control Therapeutic Cells
Assistant Professor of Genetics, Stanford School of Medicine | BIO

Serena Yeung

Serena Yeung

Precision Health's Visual Frontier: Mining Insights with Computer Vision
Assistant Professor of Biomedical Data Science and, by courtesy, of Computer Science and of Electrical Engineering, Stanford School of Medicine | BIO

12:00–1:15 pm

LUNCH AND RESEARCH INNOVATION SHOWCASE

1:15–1:45 pm

PANEL: INFORMING POLICY IN HEALTH AND SCIENCE

This session will explore the role of academic medicine in shaping sound health and science policy— from advancing public health to nurturing tomorrow’s breakthroughs.

Speakers:

Douglas Owens

Doug Owens

Chair of the Department of Health Policy, Stanford School of Medicine | BIO

Rekha Ramesh

Rekha Ramesh

Vice President, U.S. Policy, Government Affairs, Gilead Sciences, Inc. | BIO

Moderator:

Bob Kocher

Bob Kocher

Partner, Venrock | BIO

1:45 pM–2:30 pm 

FIRESIDE CHAT WITH CHELSEA CLINTON AND LLOYD MINOR
ACHIEVING GLOBAL IMPACT

Dean Minor will sit down with Chelsea Clinton to discuss the role of academia in addressing some of society’s most pressing challenges, drawing from the Clinton Global Initiative’s perspectives and insights.

Speaker:

Chelsea Clinton

Chelsea Clinton

Vice Chair, Clinton Foundation; Vice Chair, Clinton Health Access Initiative | BIO

Moderator:

Lloyd Minor

Lloyd Minor

Dean of the Stanford School of Medicine
Vice President for Medical Affairs, Stanford University | BIO

2:30–2:45 pm

BREAK

2:45–3:15 pm 

PANEL: THE FUTURE OF CLINICAL TRIALS

In this panel, we will explore the innovations, challenges, and evolving landscape of clinical trials in the next era of medicine.

Speakers:

Alyce Adams

Alyce Adams

Professor of Epidemiology and Population Health, Stanford School of Medicine;
Associate Director, Stanford Cancer Institute | BIO

Michelle Monje

Michelle Monje

Professor of Neurology and Neurological Sciences, Stanford School of Medicine | BIO

James Zou

James Zou

Assistant Professor of Biomedical Data Science, Stanford School of Medicine | BIO

Moderator:

Seven Artandi

Steve Artandi

Director, Stanford Cancer Institute | BIO

3:15–3:45 pm 

PANEL: INVESTING IN OUR PHYSICIAN-SCIENTISTS

Panelists will discuss Stanford Medicine’s strategies and commitment to supporting the journey of aspiring physician-scientists, from foundational pipeline programs to advanced training and beyond.

Speakers:

Catherine Blish

Catherine Blish

Professor of Medicine and Co-Director, Medical Scientist Training Program, Stanford School of Medicine | BIO

Maigane Diop

Maïgane Diop

MD Student, Stanford School of Medicine | BIO

Brian Kobilka

Brian Kobilka

Founder, ConfometRx; 2012 Nobel Laureate | BIO

Moderator:

Fatima Rodriguez

Fatima Rodriguez

Associate Professor of Medicine, Stanford School of Medicine | BIO

3:45 PM

Closing Remarks

Lloyd Minor

Lloyd Minor

Dean of the Stanford School of Medicine
Vice President for Medical Affairs, Stanford University | BIO

4:00–5:00 PM

BREAK

Pick up room keys at the registration table and check in to rooms

5:00–6:00 pm

Reception

6:00 PM

Dinner

AGENDA

Friday, February 2, 2024 | [9:00 - 11:45 AM]

7:30–9:00 am

BREAKFAST

9:00–9:10 am

Welcome BACK

Lloyd Minor

Lloyd Minor

Dean of the Stanford School of Medicine
Vice President for Medical Affairs, Stanford University | BIO

9:10–10:10 am

ISP 2030: LIVING OUR VISION FOR STANFORD MEDICINE

This session picks up where the November 2023 ISP Refresh Retreat left off, with a focus on helping our people “live the ISP” through their daily work.

Introduction:

David Entwistle

David Entwistle

President and CEO, Stanford Health Care | BIO

Paul King

Paul King

President and CEO, Stanford Medicine Children’s Health​ | BIO

Lloyd Minor

Lloyd Minor

Dean of the Stanford School of Medicine
Vice President for Medical Affairs, Stanford University | BIO

Speakers:

Alison Kerr

Alison Kerr

Vice President of Destination Service Lines and Chief Clinical Operations Officer, Stanford Health Care | BIO

Kevin Moody

Kevin Moody

Associate Dean of Human Resources, Facilities, Planning and Management, Stanford School of Medicine | BIO

Michael Pfeffer

Michael Pfeffer

Chief Information Officer, Stanford Health Care; Associate Dean, Stanford School of Medicine | BIO

Joyce Sackey

Joyce Sackey

Chief Equity, Diversity and Inclusion Officer, Stanford Medicine | BIO

Tina Stankovic

Tina Stankovic

Chair of Otolaryngology - Head and Neck Surgery, Stanford School of Medicine | BIO

Moderator:

Aaron Straight

Aaron Straight

Chair of Biochemistry, Stanford School of Medicine | BIO

10:10–10:40 AM

PANEL: THE CARE QUALITY JOURNEY

Panelists will delve into Stanford Medicine’s innovative strategies to uphold the highest standards of patient care and ensure equitable health outcomes for all.

Speakers:

Grace Lee

Grace Lee

Chief Quality Officer, Stanford Medicine Children's Health| BIO

David Levine

David Levine

Chief Medical Officer, Vizient | BIO

Paul Maggio

Paul Maggio

Chief Quality Officer, Stanford Health Care | BIO

Moderator:

Mary Hawn

Mary Hawn

Chair of Surgery, Stanford School of Medicine | BIO

10:40–11:40 AM

KEYNOTE: JENNIFER AAKER | WHAT REALLY MATTERS

A presentation by Jennifer Aaker on how to build more innovative, collaborative, and joyful workforces, forge stronger relationships, and create more meaningful lives.

Jennifer Aaker

Jennifer Aaker

The General Atlantic Professor, Stanford Graduate School of Business | BIO

11:40–11:45 AM

Closing Remarks

Lloyd Minor

Lloyd Minor

Dean of the Stanford School of Medicine
Vice President for Medical Affairs, Stanford University | BIO

Boxed Lunches and Departures

For any questions, please contact Robin Daines (rsieben@stanford.edu)

Copyright © 2024 Stanford Medicine. All Rights Reserved.

Legal | Privacy | Code of Conduct | Notice of Nondiscrimination

Maigane Diop

Maïgane Diop

MD Student, Stanford School of Medicine

Maïgane is a third year MD/PhD student studying uterine NK cells in pregnancy and disease in the Gaudillière and Blish labs. She’s originally from France with Senegalese & French Guyanese origins, and grew up in Maryland. She graduated from the University of Maryland, College Park with a degree in Cell Biology & Molecular Genetics and a minor in Philosophy. She’s passionate about improving translational science methods to combat health disparities and supporting students from backgrounds historically excluded from medicine and science. At Stanford, she’s been involved with SUMMA (Stanford University Minority Medical Alliance), teaching, student organization leading, clinical volunteering with a focus on obstetrics and gynecology, and singing with the Stanford Chamber Chorale. Outside of medicine and science, she enjoys reading a good novel, performing and writing music, playing instruments, learning languages, traveling with her fiancé, and playing with her cuddly pit mix pupper.

Grace Lee

Grace Lee

Chief Quality Officer, Stanford Medicine Children’s Health

Dr. Grace Lee is Chief Quality Officer and the Christopher G. Dawes Endowed Director of Quality at Stanford Medicine Children’s Health and Lucile Packard Children’s Hospital Stanford, and Associate Dean for Maternal and Child Health (Quality and Safety) and Professor of Pediatrics at Stanford University School of Medicine. She oversees the Center for Pediatric and Maternal Value that seeks to improve quality, safety, patient experience and health equity across the organization. Dr. Lee previously served as a member of the Institute of Medicine Committee (IOM) to Review Priorities in the National Vaccine Plan, the IOM Committee on the Ethical and Scientific Issues in Studying the Safety of Approved Drugs, the National Academies of Sciences, Engineering, and Medicine (NASEM) Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response, and AHRQ’s Healthcare Safety and Quality Improvement Research Study Section. She also served as a Board Member for the Society for Healthcare Epidemiology of America (SHEA), Pediatric Infectious Diseases Society (PIDS), and the National Academy of Medicine (NAM) Board on Population Health and Public Health Practice. She is currently the Chair of the U.S. Advisory Committee on Immunization Practices (ACIP) that recommends vaccines for the U.S. population, and she is an elected member of the National Academy of Medicine.
Lloyd Minor

Lloyd B. Minor

Dean of the Stanford School of Medicine
Vice President for Medical Affairs, Stanford University

Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.

As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children’s Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, “Discovering Precision Health,” describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond – a multi-decade journey enabled by Precision Health.

In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.

Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.

With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.

In 2012, Dr. Minor was elected to the National Academy of Medicine.

Paul King

Paul King

President and CEO, Stanford Medicine Children’s Health

Paul A. King joined Stanford Medicine Children’s Health in January 2019 bringing with him a distinguished career of more than 30 years as a health care executive, including leadership positions at several nationally recognized academic medical centers.

Prior to joining Stanford Medicine Children’s Health King led the University of Michigan’s C.S. Mott Children’s Hospital and Von Voigtlander Women’s Hospital as Executive Director. During his tenure, his strong leadership skills guided the strategic growth of the University of Michigan’s children’s and women’s programs and services. Prior to joining C.S. Mott Children’s Hospital, King served as president and CEO for the Pediatric Management Group, a 550-physician academic pediatric subspecialty group practice affiliated with Children’s Hospital Los Angeles (CHLA). His strong leadership record also includes senior management roles at the Mayo Clinic and the Samaritan Physicians Center.

As Stanford Medicine Children’s Health plans for continued growth and the expansion of innovation across the entire continuum of care, King’s distinguished record of accomplishment and dedication to the critically important role of pediatric and obstetric care will undoubtedly help Stanford Medicine achieve its Precision Health vision.

King is currently on the Board of Trustees for the Children’s Hospital Association and holds a bachelor’s degree in Business Administration and Economics from the University of Nebraska, at Lincoln; and a master’s degree in Health care Administration from the University of Iowa, Iowa City. King also is a Certified Medical Practice Executive.

 

Joyce Sackey

Joyce Sackey

Chief Equity, Diversity and Inclusion Officer, Stanford Medicine

Joyce A. Sackey is the inaugural Chief Diversity and Inclusion Officer (CDIO) for Stanford Medicine and Clinical Professor of Medicine and Associate Dean within the Stanford University School of Medicine. As Stanford Medicine’s CDIO, she will design, develop, and oversee enterprise-wide strategies and efforts to advance inclusive excellence, health equity and justice. In addition, Sackey will support and unify existing diversity, equity, and inclusion efforts underway and provide oversight for the implementation of recommendations issued by the Commission on Justice and Equity. Prior to joining Stanford Medicine, Sackey was Associate Provost and Chief Diversity Officer for Tufts University’s Health Sciences campuses in Boston and Grafton. She was also overseeing key diversity, equity, and Inclusion initiatives at Tufts University School of Medicine. She is a Trustee of Dartmouth College, a member of the Geisel Board of Advisors, and a member of the Board of Directors for the Shapiro Institute for Education and Research at BIDMC and HMS. Sackey received her undergraduate degree from Dartmouth College, and her medical degree from Geisel School of Medicine at Dartmouth.

David Entwistle

David Entwistle

President and CEO, Stanford Health Care

David Entwistle is president and CEO of Stanford Health Care (SHC). He joined SHC in July 2016 with extensive executive experience at leading academic medical centers. Entwistle is a passionate advocate of precision health – tailoring a treatment to a patient’s specific disease or condition as well as focusing on prevention to empower patients to take charge of their health before they become ill.

Among the factors that attracted him to SHC are the unparalleled technologies available in Silicon Valley that help advance health care through better application of technology for individuals. According to Entwistle, SHC is extremely well-situated to be able to apply innovative technology, such as wearable devices that track activity or monitor blood glucose levels, to improve health.

Before joining SHC, he served for nine years as CEO of the University of Utah Hospital & Clinics (UUHC), the only academic medical center in the Intermountain West region. While serving at UUHC, Entwistle received the Modern Healthcare “Up and Comers Award,” for significant contributions in health care administration, management or policy.

He previously served as senior vice president and chief operating officer at the University of Wisconsin Hospital and Clinics in Madison, Wis., from 2002-2007; and as vice president of professional services and joint venture operations at City of Hope National Medical Center in Duarte, Calif.

As a recognized health care thought leader, Entwistle serves on the boards of the American Hospital Association, the AAMC Council of Teaching Hospitals, the Accreditation Council for Graduate Medical Education, and Vizient. He is the past chair of the Utah Hospital Association and was appointed by the governor of Utah to the state’s Medicaid Task Force.

Tina Stankovic

Konstantina Stankovic

Professor and Chair of Otolaryngology - Head and Neck Surgery, Stanford School of Medicine

Konstantina “Tina” Stankovic is the Bertarelli Foundation Professor and Chair of the Department of Otolaryngology – Head & Neck Surgery at Stanford University School of Medicine. She is a Harvard-trained ear and skull-base surgeon and a Massachusetts Institute of Technology-trained auditory neuroscientist. Stankovic’s clinical focus is in otology and neurotology, and she previously served as Chief of the Division of Otology and Neurotology at Massachusetts Eye and Ear, a teaching hospital of Harvard Medical School. In addition to her clinical and administrative duties, she directs a basic science laboratory focused on improving diagnostics and therapeutics for sensorineural hearing loss. Stankovic has initiated and led successful cross- departmental, national, and international collaborations to develop and deploy novel molecular diagnostics and therapeutics for hearing loss and otologic diseases in general while educating the next generation of leaders in surgery and science.
Aaron Straight

Aaron Straight

Professor of Biochemistry and, by courtesy, of Chemical Systems Biology, Stanford School of Medicine

Aaron Straight began his formal training in science began at Dartmouth College where he did research on immune cell activation completing a major in Biology with a secondary focus in Art History. His research interests took him to the University of California, San Francisco to study the regulation of the cell cycle where he developed new approaches to studying eukaryotic chromosome segregation. As a postdoctoral fellow at Harvard, Straight developed new small molecules directed at myosin contractile systems for application as fast acting probes for cell division research. He established his own research group at Stanford in 2003 where his laboratory has focused on the biology of chromosomes, chromatin based epigenetic control, and the functions of noncoding RNAs in chromosome regulation. At Stanford, Straight has served as head of the Committee on Graduate Admissions and Policy for the Biosciences, as Chairman of the Biochemistry Department, member of the University Faculty Senate, and in other service roles in the School of Medicine. He is currently helping to direct the Future of Life Sciences Initiative as part of the strategic plan for the School of Medicine and University.

Alyce Adams

Alyce Adams

Professor of Epidemiology and Population Health, Stanford School of Medicine; Associate Director, Stanford Cancer Institute

Dr. Adams is the inaugural Stanford Medicine Innovation Professor and Professor of Health Policy, Epidemiology and Population Health and of Pediatrics (by Courtesy). She also serves as Associate Chair for Health Equity and Community Engagement for Stanford Health Policy, Associate Director for Health Equity and Community Engagement in the Stanford Cancer Institute, and as Associate Director for Stanford Impact Labs. Focusing on racial and socioeconomic disparities in chronic disease treatment outcomes, Dr. Adams’ interdisciplinary research seeks to evaluate the impact of changes in drug coverage policy on access to essential medications, understand the drivers of disparities in treatment adherence among insured populations, and test strategies for maximizing the benefits of treatment outcomes while minimizing harms through informed decision-making. Prior to joining Stanford School of Medicine, Dr. Adams was Associate Director for Health Care Delivery and Policy and a Research Scientist at the Kaiser Permanente Division of Research, as well as a Professor at the Bernard J. Tyson Kaiser Permanente School of Medicine. From 2000 to 2008, she was an Assistant Professor in the Department of Population Medicine (formerly Ambulatory Care and Prevention) at Harvard Medical School and Harvard Pilgrim Health Care. She received her PhD in Health Policy and an MPP in Social Policy from Harvard University. She is a member of the Board of Directors for Academy Health and a former recipient of the John M. Eisenberg Excellence in Mentoring Award from Agency for Healthcare Research and Quality.
Bob Kocher

Bob Kocher

Partner, Venrock

Bob is a Partner at Venrock and focuses on health tech and services investments. He currently serves on the Boards of Devoted Health, Virta Health, Aledade, Lyra Health, Need, Sitka, Accompany Health, Candid, and Premera Blue Cross. He is a Board Observer at SmithRx, Stride, Suki, and The Public Health Company. Additionally, he is an Adjunct Professor at Stanford University School of Medicine and a Non-Resident Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC. He also serves on the Advisory Board of the National Institute of Healthcare Management (NIHCM). Prior to Venrock, Bob served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council and as a Partner at McKinsey & Company. Bob received an undergraduate degree from the University of Washington and a medical degree from George Washington University. He completed a research fellowship with the Howard Hughes Medical Institute and the National Institutes of Health, and went on to complete his internal medicine residency training at the Beth Israel Deaconess Medical Center and the Harvard Medical School.
Brian Kobilka

Brian Kobilka

Founder, ConfometRx
2012 Nobel Laureate

Brian Kobilka, MD, is professor of molecular and cellular physiology at the Stanford University School of Medicine, California. In 2012, he won the Nobel Prize in Chemistry for his work on G-protein-coupled receptors (GPCRs). Over the course of the past three decades, Kobilka and his colleague Robert Lefkowitz, MD, with whom Kobilka shares the prize, played an important role in discovering and understanding GPCRs.

In 2011, Kobilka was the first to crystallize and analyze one of the receptors bound to its signaling molecule, which is a critical step toward understanding how to control them. Also in 2011, Kobilka and his team were the first to obtain a 3D image of the same GPCR bound to its signaling molecule—an extremely difficult technical endeavor due to the protein’s size and complexity.

Kobilka received his MD from Yale University in 1981. In 1984, he joined the Lefkowitz Laboratory at Duke University, and they began to work together to learn more about the epinephrine receptor, also known as the beta-adrenergic receptor. Kobilka isolated the gene for the receptor to learn more about its composition. When he studied the sequence, he realized that it was very similar to that of another, seemingly unrelated receptor called rhodopsin that detects light in the retina of the eye. This research helped the scientists realize that GPCRs are a large family, with many different examples throughout the body.

Kobilka continues his work in his lab at Stanford Medicine to characterize the structure and mechanism of activation of GPCRs using a variety of approaches including cell biology, gene disruption in mice, and in vivo physiology to determine the role of specific adrenergic receptor subtypes in normal physiology.

Chelsea Clinton

Chelsea Clinton, DPhil, MPH

Vice Chair, Clinton Foundation
Vice Chair, Clinton Health Access Initiative

As vice chair of the Clinton Foundation, Chelsea Clinton works alongside the Foundation’s leadership and partners to improve lives and inspire emerging leaders across the United States and around the world. This includes the Foundation’s early child initiative Too Small to Fail, which supports families with the resources they need to promote early brain and language development; and the Clinton Global Initiative University (CGI U), a global program that empowers student leaders to turn their ideas into action. A longtime public health advocate, Chelsea also serves as vice chair of the Clinton Health Access Initiative and uses her platform to increase awareness around issues such as vaccine hesitancy, childhood obesity, and health equity. In addition to her Foundation work, Chelsea teaches at Columbia University’s Mailman School of Public Health and has written several books for young readers, including the #1 New York Times bestseller She Persisted: 13 American Women Who Changed the World as well as She Persisted Around the World, She Persisted in Sports, She Persisted in Science, Start Now! You Can Make a Difference; Don’t Let Them Disappear; It’s Your World: Get Informed, Get Inspired & Get Going; and Welcome to the Big Kids Club. She is also the co-author of The Book of Gutsy Women and Grandma’s Gardens with Secretary Hillary Rodham Clinton and of Governing Global Health: Who Runs the World and Why? with Devi Sridhar. Chelsea’s podcast, In Fact with Chelsea Clinton, premiered in 2021 and is the co-founder of HiddenLight Productions. Chelsea holds a Bachelor of Arts from Stanford, a Master of Public Health from Columbia’s Mailman School of Public Health, and both a Master of Philosophy and a Doctorate in international relations from Oxford University. She lives with her husband Marc, their children Charlotte, Aidan and Jasper in New York City.
David Levine

David Levine

Chief Medical Officer, Vizient

Blending clinical leadership and informatics experience, David is responsible for driving numerous key initiatives for Vizient, including growing the Center for Advanced Analytics, leading the development of risk-adjustment methodologies and increasing the engagement of physicians and other clinicians. The Center brings together analytics from multiple clinical and operational offerings to provide insights to members across the continuum of care.

David joined the company in 2010 after serving as medical director of the emergency department at John H. Stroger Jr. Hospital of Cook County in Chicago. He also served as a physician leader for information technology upgrades, including expansion of computerized physician order entry and documentation improvements. His background includes consulting for emergency departments and physician groups to optimize informatics, quality and compliance.

David earned a doctor of medicine degree from the Northwestern University Feinberg School of Medicine and a Bachelor of Science degree in psychology from the University of Michigan. He is an assistant professor of emergency medicine at Rush Medical School in Chicago and a Fellow of the American College of Emergency Physicians.

Mildred Cho

Mildred Cho

Professor (Research) of Pediatrics (Center for Biomedical Ethics) and of Medicine (Primary Care and Population Health), Stanford School of Medicine

Mildred is the Associate Director of the Stanford Center for Biomedical Ethics. She is a Professor of Pediatrics and the Principal Investigator of the Center for Integration of Research on Genetics and Ethics (CIRGE) at Stanford University, which is funded by the NHGRI of the NIH. Her major areas of interest are the ethical and social issues raised by new technologies such as genetic testing, gene therapy, pharmacogenetics and gene patents. She also studies how academic-industry ties affect the conduct of biomedical research.

Douglas Owens

Doug Owens

Chair, Department of Health Policy, Stanford School of Medicine

Douglas K. Owens is the Henry J. Kaiser, Jr. Professor, and Professor and Chair of the Department of Health Policy in the School of Medicine, and the Director of the Center for Health Policy (CHP) in the Freeman Spogli Institute for International Studies (FSI). Owens is a Senior Fellow at FSI and, by courtesy, a Professor of Management Science and Engineering, at Stanford University. He is a general internist.

Owens’ research focuses on technology assessment, cost-effectiveness analysis, evidence synthesis, and methods for clinical decision making and guideline development. He has studied the cost-effectiveness of preventive and therapeutic interventions for HIV/AIDS in several countries; diagnostic and therapeutic interventions for cardiovascular disease; the cost effectiveness of current and emerging therapies for hepatitis C virus infection; the cost effectiveness of prevention and treatment for opioid use disorder; and he has developed methods for developing clinical practice guidelines tailored to specific patient populations. Owens chaired the Clinical Guidelines Committee of the American College of Physicians for four years. The guideline committee develops clinical guidelines that are used widely and are published regularly in the Annals of Internal Medicine. He now is again a member of the ACP guideline committee. He served as Vice-Chair and Chair of the U.S. Preventive Services Task Force, which develops national guidelines on preventive care. Owens helped lead the development of many national guidelines including screening for breast, colorectal, prostate, cervical, ovarian, pancreatic, thyroid, and lung cancer, and screening for infectious diseases, including HIV, HCV, and HBV. He was also a member of the 2nd Panel on Cost Effectiveness in Health and Medicine, which developed guidelines on the conduct of cost-effectiveness analyses published in 2016.

Owens also directed the Stanford-UCSF Evidence-based Practice Center. He co-directed three training programs in health services research: the Stanford-AHRQ Fellowship Program in Health Policy at Stanford, the VA Post-doctoral Fellowship in Health Services Research, and the VA Postdoctoral Informatics Fellowship Program. He currently is co-director of the Stanford-AHRQ Fellowship Program in Health Policy.

Owens received a BS and an MS from Stanford University, and an MD from the University of California-San Francisco. He completed a residency in internal medicine at the University of Pennsylvania and a fellowship in health research and policy at Stanford. Owens is a past-President of the Society for Medical Decision Making. He received the VA Undersecretary’s Award for Outstanding Achievement in Health Services Research, and the Eisenberg Award for Leadership in Medical Decision Making from the Society for Medical Decision Making. He was elected to the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP). In 2019, Owens received a MERIT Award from the National Institutes on Drug Abuse for his work on HIV, HCV, and the opioid epidemic.

Fatima Rodriguez

Fatima Rodriguez

Associate Professor of Medicine, Stanford School of Medicine

Fatima Rodriguez, MD, MPH is an Associate Professor in Cardiovascular Medicine and (by courtesy) the Stanford Prevention Research Center. Dr. Rodriguez earned her medical degree from Harvard Medical School and her MPH from the Harvard School of Public Health. She then completed internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford University. She currently serves as the Section Chief of Preventive Cardiology. Dr. Rodriguez specializes in cardiovascular disease prevention, inherited lipid disorders, and cardiovascular risk assessment in high-risk populations.

Dr. Rodriguez’s research includes a range of topics around racial, ethnic, and gender disparities in cardiovascular disease prevention, developing novel interventions to address disparities, and opportunistic screening of coronary artery disease.

James Zou

James Zou

Assistant Professor of Biomedical Data Science, Stanford School of Medicine

James Zou is an Assistant Professor of Biomedical Data Science and, by courtesy, of Computer Science and Electrical Engineering at Stanford University. He works on making machine learning more reliable, human-compatible and statistically rigorous, and he is especially interested in applications in human disease and health. James received his Ph.D from Harvard in 2014, and was at one time a member of Microsoft Research, a Gates Scholar at Cambridge and a Simons fellow at U.C. Berkeley. James joined Stanford in 2016 and is excited to also be a Chan-Zuckerberg Investigator. He is also a part of the Stanford AI Lab. His research is supported by the Sloan Fellowship, the NSF CAREER Award, and the Google and Tencent AI awards.
Rekha Ramesh

Rekha Ramesh

Vice President, U.S. Policy, Government Affairs
Gilead Sciences, Inc.

Rekha Ramesh is the Vice President and Head of U.S. Policy at Gilead Sciences, with expertise on the impacts of government policies on healthcare access, coverage, and reimbursement. She is a board member for the National Pharmaceutical Council, HIV + Hepatitis Policy Institute and sits on the following advisory committees: AIDSVu/HEPVu, University of Southern California Value of Life Sciences Innovation Program (VLSI), Duke Margolis Value of Medical Products Consortium, and the Harvard Health Policy Leadership Council.

Prior to joining Gilead, Rekha consulted for a public policy consulting company where she worked with governments, foundations and companies to develop policies that would provide greater access to health coverage. She started her policy career as an Analyst at the U.S. Congressional Budget Office.

She holds a Bachelor of Arts in Biology from Washington University in St. Louis and a Masters in Public Policy from the University of Chicago.

Serena Yeung

Serena Yeung

Assistant Professor of Biomedical Data Science and, by courtesy, of Computer Science and of Electrical Engineering, Stanford School of Medicine

Dr. Serena Yeung is an Assistant Professor of Biomedical Data Science and, by courtesy, of Computer Science and of Electrical Engineering at Stanford University. Her research focus is on developing artificial intelligence and machine learning algorithms to enable new capabilities in biomedicine and healthcare. She has extensive expertise in deep learning and computer vision, and has developed computer vision algorithms for analyzing diverse types of visual data ranging from video capture of human behavior, to medical images and cell microscopy images.

Dr. Yeung leads the Medical AI and Computer Vision Lab at Stanford. She is affiliated with the Stanford Artificial Intelligence Laboratory, the Clinical Excellence Research Center, the Center for Artificial Intelligence in Medicine & Imaging, the Center for Human-Centered Artificial Intelligence, and Bio-X. She also serves on the NIH Advisory Committee to the Director Working Group on Artificial Intelligence.

Catherine Blish

Catherine Blish

Professor of Medicine and Co-Director, Medical Scientist Training Program, Stanford School of Medicine

Dr. Blish is an associate program director of the Stanford MD-PhD program, an investigator of the Chan Zuckerberg Biohub, Member of Bio-X and Member of Maternal & Child Health Research Institute (MCHRI).

She received her B.S. in Biochemistry from the University of California, Davis, and a M.D. and a Ph.D. in Immunology from the University of Washington. She performed postdoctoral research in the laboratory of Julie Overbaugh before moving to Stanford in late 2011.

Michelle Monje

Michelle Monje

Professor of Neurology and Neurological Sciences, Stanford School of Medicine

Michelle Monje, MD, PhD, is a professor of Neurology and Neurological Sciences at Stanford University and a Howard Hughes Medical Institute Investigator. Her research program focuses at the intersection of neuroscience and brain cancer biology with an emphasis on neuron-glial interactions in health and oncological disease. Her lab demonstrated that neuronal activity regulates healthy glial precursor cell proliferation, new oligodendrocyte generation, and adaptive myelination; this plasticity of myelin contributes to healthy cognitive function, while disruption of myelin plasticity contributes to cognitive impairment in disease states like cancer therapy-related cognitive impairment. She discovered that neuronal activity similarly promotes the progression of malignant gliomas, driving glioma growth through both paracrine factors and through electrophysiologically functional neuron-to-glioma synapses. Dr. Monje has led several of her discoveries from basic molecular work to clinical trials. Her brain cancer neuroscience work has been recognized with numerous honors, including an NIH Director’s Pioneer Award, a MacArthur Fellowship and election to the National Academy of Medicine.
Kevin Moody

Kevin B. Moody

Associate Dean for Human Resources, Facilities, Planning and Management, Stanford School of Medicine

Kevin joined the Stanford community in April 2019 as the Associate Dean for Human Resources at the School of Medicine. In this capacity, he leads all strategic and operational aspects of the school’s staff human resources function. In May 2020, Kevin was also appointed to oversee Facilities Planning and Management, where he works closely with the Dean and Stanford Medicine leadership to address newfound issues created by COVID-19 that impact the workforce, capital projects, emergency preparedness planning and other areas of critical importance to the School of Medicine.

Kevin’s professional experience includes tenures at other private academic institutions, including Harvard University and Emory University. Most recently, Kevin served as the Assistant Dean and Chief Human Resources Officer at Harvard Law School. Prior to his time at Harvard Law School, Kevin spent over 14 years at Emory where he held numerous management roles within the Human Resources Division and the School of Law. Before embarking on his career in human resources and academia, Kevin served in the United States Marine Corps as an air traffic control operations officer at the rank of Captain until his end of active duty in 2001.

Kevin received his Bachelor of Arts in Psychology from Emory University. He also holds a Master of Science in Organizational Leadership from Brenau University in Gainesville, Georgia, and an Executive Master of Business Administration from Emory University’s Goizueta Business School. Kevin is certified in human resources as a Senior Certified Professional (SHRM-SCP) by the Society for Human Resources Management and a Senior Professional in Human Resources (SPHR) by the HR Certification Institute. Kevin currently resides in Redwood City.

Alison Kerr

Alison Kerr

Vice President of Destination Service Lines and Chief Clinical Operations Officer, Stanford Health Care

Alison Marie Kerr, RN, MSN, joined Stanford University Medical Center in September 1991 as a clinical nurse and has risen through the ranks of hospital leadership to her current role as Chief Clinical Operations Officer and Vice President, Destination Service Lines for Neuroscience, Orthopaedics, GI/GI Surgery, Cardiovascular Health, and Solid Organ Transplant. In her role as CCOO, she has operational and strategic responsibility for the Emergency Departments (adult and pediatric), Pathology/Lab services, Stanford Blood Center, Level 1 trauma and Stroke programs, and the Office of Emergency Management. In her Service Line position, she is responsible for service line performance across the health system focusing on quality/outcome measures, patient experience, budgeting, strategy, and growth.

Previous roles at Stanford include Vice President, Neuroscience, and Director of Business Development, which involved co-leading a Neuroscience Strategic plan and responsibility for ongoing business development, and programmatic growth. Ms. Kerr led the planning and building of an integrated Neuroscience Health Center; a 5-story, 92K square foot building including a Radiology platform, Infusion Center, Neurorehabilitation, and integrated clinical research space. This $80M building opened in January 2016.

Ms. Kerr has been instrumental throughout the COVID-19 pandemic, focusing on lab testing and development, pharmacy response, community partnerships, organizational capacity management and workflows, and liaising with local, state, and federal governments.

Partnering with preeminent Stanford Medicine faculty and staff to bring innovation and science directly to patients and the community has been one of the greatest joys for Ms. Kerr.

Seven Artandi

Steve Artandi

Director, Stanford Cancer Institute

Steven Artandi, MD, PhD is the Laurie Kraus Lacob Director of the Stanford Cancer Institute and the Jerome and Daisy Low Gilbert Professor of Medicine and Biochemistry at Stanford University. He also serves as the inaugural Senior Associate Dean for Cancer Programs for Stanford School of Medicine and the Chief Cancer Officer for Stanford Health Care. He received his undergraduate degree from Princeton University, and MD and PhD degrees from Columbia University. He trained in Internal Medicine at Massachusetts General Hospital and in Oncology at Dana-Farber Cancer Institute before joining the Stanford faculty in 2000. Dr. Artandi is an oncologist and cancer biologist whose research work has focused on the role played by the enzyme telomerase in cancer, aging and stem cell function. His work has produced new insights into the origins of cancer, revealing how telomerase endows cells with immortal growth properties and how aspiring cancers circumvent critical bottlenecks encountered during carcinogenesis. He has received a number of awards including an Outstanding Investigator Award from the National Cancer Institute and is an elected member of the American Association for the Advancement of Science, the American Society for Clinical Investigation and the Association of American Physicians. He serves on the Editorial Boards of the journals Molecular Cancer Research and Stem Cells.
Sherri Rose

Sherri Rose

Professor, Health Policy, Stanford University

Sherri Rose, Ph.D. is a Professor of Health Policy and Co-Director of the Health Policy Data Science Lab at Stanford University. Her research is centered on developing and integrating innovative statistical machine learning approaches to improve human health and health equity. Within health policy, Dr. Rose works on risk adjustment, ethical algorithms in health care, comparative effectiveness research, and health program evaluation. She has published interdisciplinary projects across varied outlets, including Biometrics, Journal of the American Statistical Association, Journal of Health Economics, Health Affairs, and New England Journal of Medicine. In 2011, Dr. Rose coauthored the first book on machine learning for causal inference, with a sequel text released in 2018. She has been Co-Editor-in-Chief of the journal Biostatistics since 2019.

Her honors include an NIH Director’s Pioneer Award, NIH Director’s New Innovator Award, the ISPOR Bernie J. O’Brien New Investigator Award, and Mid-Career Awards from the American Statistical Association’s Health Policy Statistics Section, Washington Statistical Society/RTI-International, and Penn-Rutgers Center for Causal Inference. Dr. Rose was named a Fellow of the American Statistical Association in 2020 and she received the 2021 Mortimer Spiegelman Award, which recognizes the statistician under age 40 who has made the most significant contributions to public health statistics. Her research has been featured in The New York Times, USA Today, and The Boston Globe.

Ruth Huttenhain

Ruth Huttenhain

Assistant Professor of Molecular and Cellular Physiology, Stanford School of Medicine

Ruth is an Assistant Professor in the Department of Molecular and Cellular Physiology at Stanford University. Her group deciphers how G protein-coupled receptors decode extracellular cues into dynamic and context-specific cellular signaling networks to elicit diverse physiologic responses. They exploit quantitative proteomics to capture the spatiotemporal organization of signaling networks combined with functional genomics to study their impact on physiology.
Jennifer Aaker

Jennifer Aaker

The General Atlantic Professor, Stanford Graduate School of Business

Dr. Jennifer Aaker is the General Atlantic Professor at Stanford Graduate School of Business. A behavioral scientist and author, Dr. Aaker is a leading expert on how meaning and purpose shape the choices individuals make, how money and time can be used in ways that cultivate long-lasting happiness, and how technologies including Artificial Intelligence (AI) and Mixed Reality (XR) are redefining human interaction. She is widely published in leading scientific journals and her work has been featured in The Economist, The New York Times, The Wall Street Journal, The Washington Post, BusinessWeek, Forbes, NPR, CBS MoneyWatch, Inc., and Science.

Dr. Aaker is the coauthor of several books including the award-winning book, The Dragonfly Effect, which has been translated into over 10 languages, as well as Power of Story, which drew on behavioral science to provide a hands-on tool putting The Dragonfly Effect model to work. She worked with a group of Stanford students to get over 100,000 people into the bone marrow registry, a target that they achieved in under one year. Her new book, Humor, Seriously, is focused on why humor is a window into our humanity, and how it can be used as a secret weapon in business and life (with Naomi Bagdonas, Penguin, 2020).

At Stanford, she teaches classes including Designing AI to Cultivate Human Well-Being, Rethinking Purpose, A New Type of Leader, VR/AR: Scaling Empathy in an Immersive World, Power of Story, and Humor: Serious Business. She is the recipient of the Distinguished Scientific Achievement Award, Stanford Distinguished Teaching Award, Citibank Best Teacher Award, George Robbins Best Teacher Award, Robert Jaedicke Silver Apple Award, and the MBA Professor of the Year Award.

Peter Lee

Peter Lee

Corporate Vice President, Research and Incubations, Microsoft

Dr. Peter Lee is Corporate Vice President of Research and Incubations at Microsoft. He leads Microsoft Research and incubates new research-powered products and lines of business in areas such as artificial intelligence, computing foundations, health, and life sciences. He speaks and writes widely on science and technology trends. Before joining Microsoft in 2010, he was at DARPA, where he established a new technology office that created operational capabilities in machine learning, data science, and computational social science. Prior to that, he was a professor and the head of the computer science department at Carnegie Mellon University. Dr. Lee is a member of the National Academy of Medicine and serves on the Boards of Directors of several institutes for the Allen Institute for Artificial Intelligence, the Brotman Baty Institute for Precision Medicine, and the Kaiser Permanente Bernard J. Tyson School of Medicine. He served on President Obama’s Commission on Enhancing National Cybersecurity and led studies for PCAST and the National Academies. He has testified before both the US House Science and Technology Committee and the US Senate Commerce Committee. With Carey Goldberg and Dr. Isaac Kohane, he is the coauthor of the book, “The AI Revolution in Medicine: GPT-4 and Beyond.”
Paul Maggio

Paul Maggio

Chief Quality Officer, Stanford Health Care

Dr. Paul Maggio is a Professor of Surgery, Chief Quality Officer for Stanford Health Care, and Associate Dean for Quality and Clinical Affairs in the Stanford School of Medicine. He trained in General Surgery at Brown University and obtained advanced training in Adult Surgical Critical Care and Trauma at the University of Michigan. He holds a Master of Business Administration from the University of Michigan and is triple board certified in General Surgery, Critical Care, and Medical Informatics. His clinical focus is on Acute Care Surgery and Critical Care Medicine, and his academic career has been centered on quality improvement, patient safety, and the application of systems engineering to enhance the delivery of healthcare.

Dr. Maggio participates in the National Committee on Healthcare Engineering for the American College of Surgeons and has served on the Baldrige Board of Examiners to recognize organizations with the highest presidential honor for performance excellence. Dr. Maggio received the SHC Board of Hospital Director’s Denise O’Leary Award for Clinical Excellence in 2013.

Michael Pfeffer

Michael Pfeffer

Chief Information Officer, Stanford Health Care
Associate Dean, Stanford School of Medicine

Michael A. Pfeffer, MD, FACP serves as Chief Information Officer and Associate Dean for Stanford Health Care and Stanford University School of Medicine. Michael oversees Technology and Digital Solutions (TDS), responsible for providing world class technology solutions to Stanford Health Care and School of Medicine, enabling new opportunities for groundbreaking research, teaching, and compassionate care across two hospitals and over 150 clinics. TDS supports Stanford Medicine’s mission to improve human health through discovery and care and strategic priorities to be value focused, digitally driven, and uniquely Stanford.

Michael is a Clinical Professor in the Department of Medicine and Division of Hospital Medicine with a joint appointment in the center for Biomedical Research (BMIR) in Stanford University School of Medicine. As such, Michael continues to provide clinical care as a Hospitalist Physician as well as teaching medical students and residents on the medicine inpatient wards.

Prior to joining Stanford Medicine, Michael served as the Assistant Vice Chancellor and Chief Information Officer for UCLA Health Sciences. During his tenure, Michael served as the lead physician for the largest electronic health record “big bang” go-live of its time, encompassing over 26,000 users. Michael subsequently became the first Chief Medical Informatics Officer for UCLA Health before transitioning into the Chief Information Officer position. Under his leadership, UCLA Health IT achieved numerous industry awards including the HIMSS Analytics Stage 7 Inpatient, Ambulatory, and Analytics Certifications; the Most Wired designation for eight consecutive years; US News & World Report’s Most Connected Hospitals; the Top Master’s in Healthcare Administration 30 Most Technologically Advanced Hospitals in the World; and the prestigious HIMSS Davies Award. Michael also implemented of one of the first ACGME-accredited Clinical Informatics Fellowship Programs and served as its Associate Program Director.

Mary Hawn

Mary Hawn

Chair of Surgery, Stanford Medicine

Dr. Mary T. Hawn is the Stanford Medicine Professor of Surgery and Chair of the Department of Surgery at Stanford University. Dr. Hawn, a native of Michigan, received her education and surgical training at the University of Michigan. Her clinical area of specialty is minimally invasive foregut surgery. Dr. Hawn is a funded health services researcher and her projects focus on quality measurement and policy in surgical populations. She is a Director for the American Board of Surgery and serves on the editorial board of Annals of Surgery, Journal of the American College of Surgeons, Journal of Gastrointestinal Surgery and the American Journal of Surgery. Dr. Hawn has several additional leadership roles in American Surgery including Chair of the American College of Surgeons Scientific Forum Committee and as a Trustee and Treasurer for the Surgical Society of the Alimentary Tract. She is the co-Editor of a new surgical textbook Operative Techniques in Surgery.
Kyle Daniels

Kyle Daniels

Assistant Professor of Genetics, Stanford School of Medicine

Kyle obtained his BS in Biochemistry from the University of Maryland College Park in 2010, conducting undergraduate research with Dr. Dorothy Beckett, PhD. He obtained his PhD in Biochemistry with a certificate in Structural Biology and Biophysics. His dissertation is titled “Kinetics of Coupled Binding and Conformational Change in Proteins and RNA” and was completed in the laboratory of Dr. Terrence G. Oas, PhD. Kyle performed postdoctoral training with Dr. Wendell A. Lim, PhD at UCSF studying how CAR T cell phenotype is encoded by modular signaling motifs within chimeric antigen receptors.

Kyle’s lab is interested in harnessing the principles of modularity to engineer receptors and gene circuits to control cell functions.

The lab will use synthetic biology, medium- and high-throughput screens, and machine learning to: (1) Engineer immune cells to achieve robust and durable responses against various cancer targets, (2) Coordinate behavior of multiple engineered cell types in cancer, autoimmune disease, and payload delivery, (3) Control survival, proliferation, and differentiation of hematopoietic stem cells (HSCs) and immune cells, and (4) Explore principles of modularity related to engineering receptors and gene circuits in mammalian cells.

Kacper Rogala

Kacper Rogala

Assistant Professor of Structural Biology and of Chemical and Systems Biology, Stanford School of Medicine

Dr. Kacper Rogala is Assistant Professor at Stanford University School of Medicine with a joint appointment between the Department of Structural Biology and the Department of Chemical & Systems Biology. He is also a Leader in the Stanford Cancer Institute.

Kacper was born and raised in Poland, and educated in three wonderful British cities: Oxford, London and Edinburgh, where he studied chemistry of living things, or simply — biochemistry. During his studies, Kacper developed a deep passion for proteins — how they work, what they look like, and how they interact with other proteins and small molecules. This passion led him to pursue a trans-Atlantic postdoc between two Cambridges: one in the UK and one in Massachusetts. As a researcher at MIT, the Whitehead Institute, the Broad Institute, and the MRC Laboratory of Molecular Biology, Kacper began unraveling the mechanisms of nutrient sensing on the surface of lysosomes.

Kacper joined Stanford as an assistant professor in 2022, and together with his team they are leading the charge towards mechanistic understanding of how cells control metabolism in response to nutrients and growth factors, and ways to modulate these activities with chemical probes — for the benefit of patients.

Lloyd B. Minor

Dean, Stanford School of Medicine

Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, a position he has held since December 2012. He also is a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.

As dean, Dr. Minor plays an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children’s Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, “Discovering Precision Health,” describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond – a multi-decade journey enabled by Precision Health.

Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.

With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.

In 2012, Dr. Minor was elected to the National Academy of Medicine.